Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

Trial Profile

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs Florbetapir F 18 (Primary)
  • Indications Alzheimer's disease; Cognition disorders
  • Focus Diagnostic use
  • Acronyms RAmP
  • Sponsors Avid Radiopharmaceuticals
  • Most Recent Events

    • 28 Nov 2016 Status changed from not yet recruiting to recruiting.
    • 04 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top